Trials / Active Not Recruiting
Active Not RecruitingNCT05389267
Safety Assessment of T4090 Eye Drops in Ocular Hypertensive or Glaucomatous Patients.
- Status
- Active Not Recruiting
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 120 (estimated)
- Sponsor
- Laboratoires Thea · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The study purpose is to evaluate the safety of T4090.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Kinezodianone R hydrochloride | Eyedrops |
| DRUG | Placebo | Placebo |
Timeline
- Start date
- 2022-07-05
- Primary completion
- 2024-12-31
- Completion
- 2024-12-31
- First posted
- 2022-05-25
- Last updated
- 2024-02-07
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT05389267. Inclusion in this directory is not an endorsement.